Target intelligence / Profile preview

Solute carrier organic anion transporter family member 4C1 (SLCO4C1) (SLCO4C1)

Target
SLCO4C1
Molecular classification
Transporter, Solute carrier family, Organic anion transporting polypeptide
01

Overview

Solute carrier organic anion transporter family member 4C1 (SLCO4C1), also known as OATP4C1, is a multispecific uptake transporter primarily localized to the basolateral membrane of the renal proximal tubule (UniProt: P5G377). It is uniquely characterized as the first kidney-specific member of the OATP family, playing a pivotal role in the renal secretion of various substrates including thyroid hormones (T3, T4), cAMP, and cardiac glycosides like digoxin (Mikkaichi et al., 2004, PNAS). Beyond drug transport, SLCO4C1 is essential for the clearance of uremic toxins such as guanidinosuccinate and asymmetric dimethylarginine (ADMA), which are linked to the progression of chronic kidney disease (CKD) and cardiovascular complications (Toyohara et al., 2009, J Am Soc Nephrol). Research suggests that upregulating SLCO4C1 could serve as a therapeutic strategy to reduce uremic toxins and lower blood pressure in patients with renal failure. Its involvement in the transport of narrow-therapeutic-index drugs like digoxin makes it a critical site for potential drug-drug interactions (NCBI Gene: 353189). Furthermore, SLCO4C1 expression is regulated by the pregnane X receptor (PXR), suggesting that certain drugs could modulate its activity to improve renal function (Toyohara et al., 2009).

Other names
OATP4C1OATP-HSLC21A20Organic anion-transporting polypeptide 4C1
02

Mechanism of action

Facilitates the uptake of organic anions and xenobiotics from the blood into renal proximal tubule cells for subsequent excretion into the urine.

03

Biological functions

Renal excretionUremic toxin clearanceThyroid hormone transportOrganic anion transportTransmembrane transport
04

Disease associations

Chronic kidney diseaseUremiaHypertensionCardiovascular disease
05

Safety considerations

Drug-drug interactionsUremic toxin accumulationAltered drug clearance in renal impairment
06

Interacting drugs

Digoxin

5 more in the full profile.

07

Biomarkers

GuanidinosuccinateAsymmetric dimethylarginine (ADMA)Plasma digoxin levels

Beyond the preview

Go deeper on Solute carrier organic anion transporter family member 4C1 (SLCO4C1) (SLCO4C1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier organic anion transporter family member 4C1 (SLCO4C1) (SLCO4C1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call